RNA interference of IL-10 in leukemic B-1 cells

Cancer Immunity

Volumn 4, Issue , 2004, Pages

  McCarthy, Brian A ^a   Mansour, Amal ^a   Lin, Yi Chu ^a   Kotenko, Sergei ^a   Raveche, Elizabeth ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Apoptosis; B 1 cell line; Cell cycle; Chronic lymphocytic leukemia; IL 10; RNA interference

Indexed keywords

INTERLEUKIN 10; PHOSPHATASE; PROTEIN; PROTEIN BCL 7C; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CELL CYCLE G2 PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; LEUKEMIA CELL; METAPHASE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RNA INTERFERENCE;

EID: 13444288003     PISSN: 14249634     EISSN: 14249634     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Fluckiger A, Durand I, Banchereau J. IL-10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J Exp Med 1994; 179: 91-9. (PMID: 8270886)
2. Jurlander J, Chun-Fai L, Tan J, Chuan-Chu C, Geisler CH, Schriber J, Blumenson LE, Narula SK, Baumann H, Caligiuri MA. Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells. Blood 1997; 89: 4146-52. (PMID: 9166857)
3. Morabito F, Filangeri M, Sculli G, Oliva B. In vitro modulation of bcl-2 protein expression, drug-induced apoptosis and cytotoxicity by interleukin-10 in chronic lymphocytic leukemia. Haematologica 1998; 83: 1046-8. (PMID: 9864930)
4. Knauf WU, Ehlers B, Bisson S, Thiel E. Serum levels of interleukin-10 in B-cell chronic lymphocytic leukemia. Blood 1995; 88: 4382-3. (PMID: 7492801)
5. Kamper EF, Papaphilis AD, Angelopoulou MK, Kopeikina LT, Siakantaris MP, Pangalis GA, Stavridis JC. Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia. Clin Biochem 1999; 32: 639-45. (PMID: 10638947)
6. Fayad L, Keating MJ, Reuben JM, O'Brien S, Lee BN, Lerner S, Kurzrock R. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood 2001; 97: 256-63. (PMID: 11133769)
7. Peng B, Sherr DH, Mahboudi F, Hardin J, Sharer L, Raveche ES. A cultured malignant B-1 line serves as a model for Richter's syndrome. J Immunol 1994; 153: 1869-80. (PMID: 8046247)
8. Phillips J, Mehta K, Fernandez C, Raveche ES. The NZB mouse as a model for CLL. Cancer Res 1992; 52: 437-43. (PMID: 1370214)
9. Czarneski J, Lin Y, Chong S, McCarthy B, Parker G, Fernandes H, DeCotiis C, Huppi K, Marti G, Mansour A, Raveche ES. Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B cell lymphoma. Leukemia 2004; 18: 597-606. (PMID: 14712288)
10. Parker G, Peng B, He M, Gould-Fogerite S, Chou C, Raveche ES. In vivo and in vitro antiproliferative effects of antisense IL-10 oligonucleotides. Meth Enzymol 1999; 314: 411-29. (PMID: 10565029)
11. Ramachandra S, Metcalf R, Fredrickson T, Marti G, Raveche ES. Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL J Clin Invest 1996; 98: 1788-93. (PMID: 8878429)
12. Chong SY, Lin YC, Czarneski J, Zhang M, Coffman F, Kashanchi F, Raveche ES. Cell cycle effects of IL-10 on malignant B-1 cells. Genes Immun 2001; 2: 239-47. (PMID: 11528515)
13. Guo S, Kemphues KJ. Par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell 1995; 81: 611-20. (PMID: 7758115)
14. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-11. (PMID: 9486653)
15. Napoli C, Lemieux C, Jorgensen RA. Introduction of a chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 1990; 2: 279-89. (PMID: 12354959)
16. Jorgensen RA, Cluster PD, English J, Que Q, Napoli CA. Chalcone synthase cosuppression phenotypes in petunia flowers: comparison of sense vs. antisense constructs and single-copy vs. complex T-DNA sequences. Plant Mol Biol 1996; 31: 957-73. (PMID: 8843939)
17. Ingelbrecht I, Van Houdt H, Van Montagu M, Depicker A. Posttranscriptional silencing of reporter transgenes in tobacco correlates with DNA methylation. Proc Natl Acad Sci U S A 1994; 91: 10502-6. (PMID: 7937983)
18. Cogoni C, Irelan JT, Schumache M, Schmidhauser T, Selker EU, Macino G. Transgene silencing of the al-1 gene in vegetative cells of Neurospora is mediated by a cytoplasmic effector and does not depend on DNA-DNA interactions or DNA methylation. EMBO J 1996; 15: 3153-63. (PMID: 8670816)
19. Shi Y. Mammalian RNAi for the masses. Trends Genet 2003; 19: 9-12. (PMID: 12493242)
20. Hannon GJ. RNA interference. Nature 2002; 418: 244-51. (PMID: 12110901)
21. McManus MT, Sharp PA. Gene silencing in mammals by small interfering RNAs [review]. Nat Rev Genet 2002; 3: 737-47. (PMID: 12360232)
22. Guru T. A silence that speaks volumes. Nature 2000; 404: 804-8. (PMID: 10786767)
23. Cogoni C, Macino G. Post-transcriptional gene silencing across kingdoms. Curr Opin Genet Dev 2000; 10: 638-43. (PMID: 11088014)
24. Kennerdell JR, Carthew RW. Heritable gene silencing in Drosophila using double-stranded RNA. Nat Biotechnol 2000; 18: 896-8. (PMID: 10932163)
25. Lum L, Yao S, Mozer B, Rovescalli A, Von Kessler D, Nirenberg M, Beachy PA. Identification of hedgehog pathway components by RNAi in Drosophila cultured cells. Science 2003; 299: 2039-45. (PMID: 12663920)
26. Sui G, Soohoo C, Affar EB, Gay F, Shi Y, Forrester WC, Shi Y. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci U S A 2002; 99: 5515-20. (PMID: 11960009)
27. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-8. (PMID: 11373684)
28. Paddison PJ, Caudy A, Hannon GJ. Stable suppression of gene expression by RNAi in mammalian cells. Proc Natl Acad Sci U S A 2002; 99: 1443-8. (PMID: 11818553)
29. Paul CP, Good PD, Winer I, Engelke DR. Effective expression of small interfering RNA in human cells. Nat Biotechnol 2002; 20: 505-8. (PMID: 11981566)
30. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-3. (PMID: 11910072)
31. Zuker M, Stiegler P. Optimal computer folding of large RNA sequences using thermodynamic and auxiliary information. Nucleic Acids Res 1981; 9: 133-48. (PMID: 6163133)
32. Hofacker IL, Fontana W, Stadler PF, Bonhoeffer S, Tacker M, Schuster P. Fast folding and comparison of RNA secondary structures. Monatsh Chem 1994; 125: 167-188.
33. McCaskill JS. The equilibrium partition function and base pair binding probabilities for RNA secondary structures. Biopolymers 1990; 29: 1105-19. (PMID: 1695107)
34. Kretschmer-Kazemi Far R, Sczakiel G. The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides. Nucleic Acids Res 2003; 31: 4417-24. (PMID: 12888501)
35. Tabara H, Grishok A, Mello CC. RNAi in C. elegans: soaking in the genome sequence. Science 1998; 282: 430-1. (PMID: 9841401)
36. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081-95. (PMID: 2531194)
37. Rennick D, Fort MM, Davidson NJ. Studies with IL-10 mice: an overview. J Leukco Biol 1997; 61: 389-96. (PMID: 9103224)
38. Lalani I, Bhol K, Ahmed AR. Interleukin-10: biology, role in inflammation and autoimmunity. Ann Allergy Asthma Immunol 1997; 79: 469-83. (PMID: 9433360)
39. Mullins DW, Martins RS, Burger CJ, Elgert KD. Tumor cell-derived TGF- and IL-10 dysregulate paclitaxel-induced macrophage activation. J Leukoc Biol 2001; 69: 129-37. (PMID: 11200057)
40. Malefyt R. Interleukin 10. London: Academic Press; 1998.
41. O'Garra A, Chang R, Go N, Hastings R, Haughton G, Howard M. Ly-IB (B-1) cells are the main source of B-cell-derived interleukin-10. Eur J Immunol 1992; 22: 711-7. (PMID: 1547817)
42. De Vita F, Orditura M, Galizia G, Romano C, Infusino S, Auriemma A, Lieto E, Catalano G. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer 1999; 86: 1936-43. (PMID: 10570416)
43. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-11. (PMID: 10676951)
44. Alas S, Emmanouilides C, Bonavida B. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis. Clin Cancer Res 2001; 7: 709-23. (PMID: 11297268)
45. National Cancer Institute CGAP Gene Ontology browser. URL: http://cgap.nci.nih.gov/Genes/GOBrowser
46. Gary-Gouy H, Harriague J, Bismuth G, Platzer C, Schmitt C, Dalloul AH. Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 2002; 100: 4537-43. (PMID: 12393419)
47. Finbloom DS, Winestock KD. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol 1995; 155: 1079-90. (PMID: 7543512)
48. Alas S, Bonavida B. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis. Clin Cancer Res 2003; 9: 316-26. (PMID: 12538484)
49. Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fuji-tani Y, Yamaguchi T, Nakajima K, Hirano T. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 1996; 5: 449-60. (PMID: 8934572)
50. Karras JG, Wang Z, Huo L, Howard RG, Frank DA, Rothstein TL. Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes. J Exp Med 1997; 185: 1035-42. (PMID: 9091577)
51. Morabito F, Filangeri M, Callea I, Sculli G, Callea V, Fracchiolla NS, Neri A, Brugiatelli M. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with the in vitro sensitivity to chlorambucil and purine analogs. Haematologica 1997; 82: 16-20. (PMID: 9107076)
52. Jadayel D, Osborne LR, Zani VJ, Coignet LFA, Tsui LC, Scherer SW, Dyer MJS. The BCL7 gene family: deletion of the BCL7B gene in Williams syndrome. Gene 1998; 224: 35-44. (PMID: 9931421)
53. Vrhovac R, Delmer A, Tang R, Marie JP, Zittoun R, Ajchenbaum-Cymbalista F. Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia. Blood 1998; 91: 4694-700. (PMID: 9616167)
54. Magnac C, Porcher R, Davi F, Nataf J, Payelle-Brogard B, Tang RP, Oppezzo P, Levy V, Digheiro G, Ajchenbaum-Cymbalista F. Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL. Leukemia 2003; 17: 133-7. (PMID: 12529670)
55. Klein U, Tu Y, Stolovitsky GA, Mattioli M, Cattoretti G, Husson H, Freedman A, Inghirami G, Cro L, Baldini L, Neri A, Califano A, Dalla-Tavera R. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001; 194: 1625-38. (PMID: 11733577)
56. Jelinek DF, Tschumper RC, Stolovitzky GA, Iturria SJ, Tu Y, Lepre J, Shah N, Kay NE. Identification of a global gene expression signature of B-chronic lymphocytic leukemia. Mol Cancer Res 2003; 1: 346-61. (PMID: 12651908)
57. Krek W, Nigg E. Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34cdc2 kinase activation in vertebrates. EMBO J 1991; 10: 3331-41. (PMID: 1655418)
58. Graeber TG, Eisenberg D. Bioinformatic identification of potential autocrine signaling loops in cancers from gene expression profiles. Nat Genet 2001; 29: 295-300. (PMID: 11685206)
59. Lieberman J, Song E, Lee SK, Shankar P. Interfering with disease: opportunities and roadblocks to harnessing RNA interference. Trends Mol Med 2003; 9: 397-403. (PMID: 13129706)
60. Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P, Lieberman J. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003; 9: 347-51. (PMID: 12579197)
61. Lin SL, Ying SY. D-RNAi (messenger RNA-antisense DNA interference) as a novel defense system against cancer and viral infections. Curr Cancer Drug Targets 2001; 1: 241-7. (PMID: 12188882)
62. Kontoyiannis D, Kotlyarov A, Carballo E, Alexopoulou L, Blackshear PJ, Gaestel M, Davis R, Flavell R, Kollias G. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J 2001; 20: 3760-70. (PMID: 11447117)
63. Boese QF, Scaringe SA, Marshall WS. siRNA as a tool for streamlining functional genomic studies. Targets 2003; 2: 93.
64. Leemans JC, Juffermans NP, Florquin S, van Rooijen N, Vervoordeldonk MJ, Verbon A, van Deventer SJH, van der Poll T. Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J Immunol 2001; 166: 4604-11. (PMID: 11254718)
65. Czarneski J, Lin YC, Chong S, McCarthy B, Fernandes H, Parker G, Mansour A, Huppi K, Marti GE, Raveche E. Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma. Leukemia 2004; 18: 597-606. (PMID: 14712288)
66. National Center for Biotechnology Information web site. URL: http://www.ncbi.nlm.nih.gov/
67. The Zuker Group: Algorithms, thermodynamics and databases for RNA secondary structure. URL: http://www.bioinfo.rpi.edu/~zukerm/rna/
68. Tuschl T, Zamore PD, Lehmann R, Bartel DP, Sharp PA. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev 1999; 13: 3191-7. (PMID: 10617568)
69. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63. (PMID: 6606682)
70. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139: 271-9. (PMID: 1710634)